Theratechnologies (THTX) Competitors $1.79 +0.13 (+7.83%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends THTX vs. CMPS, FHTX, ACIU, AMLX, LFCR, ITOS, ELDN, URGN, RZLT, and AVIRShould you be buying Theratechnologies stock or one of its competitors? The main competitors of Theratechnologies include COMPASS Pathways (CMPS), Foghorn Therapeutics (FHTX), AC Immune (ACIU), Amylyx Pharmaceuticals (AMLX), Lifecore Biomedical (LFCR), iTeos Therapeutics (ITOS), Eledon Pharmaceuticals (ELDN), UroGen Pharma (URGN), Rezolute (RZLT), and Atea Pharmaceuticals (AVIR). These companies are all part of the "pharmaceutical products" industry. Theratechnologies vs. COMPASS Pathways Foghorn Therapeutics AC Immune Amylyx Pharmaceuticals Lifecore Biomedical iTeos Therapeutics Eledon Pharmaceuticals UroGen Pharma Rezolute Atea Pharmaceuticals Theratechnologies (NASDAQ:THTX) and COMPASS Pathways (NASDAQ:CMPS) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, community ranking, risk, earnings, analyst recommendations, institutional ownership, valuation and media sentiment. Do analysts rate THTX or CMPS? COMPASS Pathways has a consensus price target of $33.60, suggesting a potential upside of 746.35%. Given COMPASS Pathways' higher probable upside, analysts clearly believe COMPASS Pathways is more favorable than Theratechnologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Theratechnologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00COMPASS Pathways 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer THTX or CMPS? In the previous week, Theratechnologies and Theratechnologies both had 2 articles in the media. COMPASS Pathways' average media sentiment score of 1.53 beat Theratechnologies' score of 0.00 indicating that COMPASS Pathways is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Theratechnologies 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral COMPASS Pathways 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do insiders and institutionals hold more shares of THTX or CMPS? 46.2% of COMPASS Pathways shares are held by institutional investors. 4.3% of COMPASS Pathways shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the MarketBeat Community believe in THTX or CMPS? COMPASS Pathways received 31 more outperform votes than Theratechnologies when rated by MarketBeat users. Likewise, 80.00% of users gave COMPASS Pathways an outperform vote while only 52.73% of users gave Theratechnologies an outperform vote. CompanyUnderperformOutperformTheratechnologiesOutperform Votes2952.73% Underperform Votes2647.27% COMPASS PathwaysOutperform Votes6080.00% Underperform Votes1520.00% Which has more volatility & risk, THTX or CMPS? Theratechnologies has a beta of 1.42, suggesting that its stock price is 42% more volatile than the S&P 500. Comparatively, COMPASS Pathways has a beta of 2.24, suggesting that its stock price is 124% more volatile than the S&P 500. Which has higher earnings and valuation, THTX or CMPS? Theratechnologies has higher revenue and earnings than COMPASS Pathways. Theratechnologies is trading at a lower price-to-earnings ratio than COMPASS Pathways, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTheratechnologies$84.32M0.98-$23.96M-$0.10-17.90COMPASS PathwaysN/AN/A-$118.46M-$2.20-1.80 Is THTX or CMPS more profitable? COMPASS Pathways has a net margin of 0.00% compared to Theratechnologies' net margin of -3.75%. Theratechnologies' return on equity of 0.00% beat COMPASS Pathways' return on equity.Company Net Margins Return on Equity Return on Assets Theratechnologies-3.75% N/A -4.31% COMPASS Pathways N/A -63.85%-51.97% SummaryCOMPASS Pathways beats Theratechnologies on 10 of the 15 factors compared between the two stocks. Ad Weiss RatingsNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …Find out details on these three critical Nvidia partners immediately. Get Theratechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for THTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart THTX vs. The Competition Export to ExcelMetricTheratechnologiesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$76.33M$6.57B$5.14B$9.08BDividend YieldN/A3.00%5.09%4.23%P/E Ratio-17.9010.5990.0517.18Price / Sales0.98195.801,117.00116.99Price / CashN/A57.1642.9637.86Price / Book-3.985.094.784.78Net Income-$23.96M$151.83M$120.31M$225.60M7 Day Performance17.76%-2.13%-1.92%-1.23%1 Month Performance47.93%-3.10%11.50%3.36%1 Year Performance12.58%11.54%30.59%16.60% Theratechnologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)THTXTheratechnologiesN/A$1.79+7.8%N/A+16.2%$76.33M$84.32M-17.90140High Trading VolumeCMPSCOMPASS Pathways2.8299 of 5 stars$4.29+1.7%$33.60+683.2%-47.3%$293.53MN/A-1.92120Positive NewsFHTXFoghorn Therapeutics2.8809 of 5 stars$5.27-0.6%$16.00+203.6%-14.0%$292.98M$25.52M-2.63120Analyst ForecastAnalyst RevisionNews CoverageHigh Trading VolumeACIUAC Immune2.4741 of 5 stars$2.95flat$12.00+306.8%-33.8%$291.87M$16.48M-6.41140Positive NewsAMLXAmylyx Pharmaceuticals4.2561 of 5 stars$4.18+1.5%$7.33+75.4%-70.7%$286.53M$196.49M-1.08200Short Interest ↓News CoveragePositive NewsLFCRLifecore Biomedical2.9045 of 5 stars$7.71+1.3%$10.00+29.7%+18.7%$283.94M$128.44M97.50690ITOSiTeos Therapeutics3.5018 of 5 stars$7.72+0.5%$25.25+227.1%-28.4%$282.04M$35M-2.4490Analyst ForecastELDNEledon Pharmaceuticals2.9252 of 5 stars$4.49+2.5%$16.00+256.3%+196.6%$268.23MN/A-2.3310Positive NewsHigh Trading VolumeURGNUroGen Pharma3.8754 of 5 stars$11.33-0.2%$43.70+285.7%-28.4%$265.69M$82.71M-3.60200RZLTRezolute3.1803 of 5 stars$4.56-0.7%$24.13+429.1%+387.8%$264.22MN/A-3.6140Positive NewsAVIRAtea Pharmaceuticals3.0689 of 5 stars$3.12+6.5%$6.88+120.5%+5.6%$263.53M$351.37M-1.5370High Trading Volume Related Companies and Tools Related Companies CMPS Competitors FHTX Competitors ACIU Competitors AMLX Competitors LFCR Competitors ITOS Competitors ELDN Competitors URGN Competitors RZLT Competitors AVIR Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:THTX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theratechnologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Theratechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
